Bruker Q1 2025 Earnings Report
Key Takeaways
Bruker delivered an 11.0% increase in revenue in Q1 2025, supported by acquisitions and moderate organic growth. Despite strong execution, the company reported a sharp decline in GAAP net income and EPS due to integration costs from 2024 acquisitions. Operating margin expanded on a non-GAAP basis thanks to proactive cost management. The company revised its FY2025 guidance downward due to academic market weakness and tariff impacts.
Revenue rose 11.0% YoY to $801,400,000, including 2.9% organic growth.
GAAP EPS dropped to $0.11, while non-GAAP EPS was $0.47.
Net income fell significantly to $17,400,000 from $50,900,000 a year ago.
Non-GAAP operating income improved slightly to $101,700,000 despite acquisition-related headwinds.
Bruker
Bruker
Bruker Revenue by Segment
Bruker Revenue by Geographic Location
Forward Guidance
Bruker adjusted its FY2025 guidance downward due to macroeconomic uncertainties, tariffs, and academic market weakness, but expects long-term margin expansion and EPS growth to resume in 2026.
Positive Outlook
- FY2025 revenue expected between $3.48B and $3.55B
- Includes 0% to 2% organic revenue growth
- Non-GAAP EPS forecasted between $2.40 and $2.48
- Anticipates resumption of EPS growth in 2026
- Cost and pricing initiatives to partially offset headwinds
Challenges Ahead
- Lowered organic revenue growth guidance for FY2025
- Tariff and policy changes impacting EPS outlook
- Academic market weakness continues to weigh on growth
- Expected margin headwinds from strategic acquisitions
- Foreign exchange translation remains a negative factor
Revenue & Expenses
Visualization of income flow from segment revenue to net income